Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Pharma
Gilead inks $202M deal to resolve long-running kickbacks case
Authorities say Gilead paid honoraria payments, meals and travel expenses to induce participants at educational HIV programs to prescribe its drugs.
Eric Sagonowsky
Apr 29, 2025 4:15pm
Gilead stands by long-acting PrEP launch amid policy uncertainties
Apr 25, 2025 11:29am
Gilead mounts campaign to close UK’s ‘HIV gender gap’
Apr 23, 2025 11:50am
GSK’s ViiV plots next steps to fight HIV in Black communities
Feb 7, 2025 1:58pm
GSK questions Gilead's potential dominance of the PrEP market
Feb 6, 2025 2:20pm
GSK raises long-term sales goal—again—despite vaccines woes
Feb 5, 2025 11:06am
